Thomas Todoran to Triiodobenzoic Acids
This is a "connection" page, showing publications Thomas Todoran has written about Triiodobenzoic Acids.
Connection Strength
0.207
-
Randomized, Double-Blind Study Comparing Patient Comfort and Safety Between Iodixanol 320 mg I/mL and Iopamidol 370 mg I/mL in Patients Undergoing Peripheral Arteriography - The COMFORT II Trial. J Invasive Cardiol. 2017 01; 29(1):9-15.
Score: 0.135
-
The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty. J Med Econ. 2018 Apr; 21(4):356-364.
Score: 0.036
-
Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention. J Comp Eff Res. 2018 04; 7(4):331-341.
Score: 0.036